Janux Therapeutics
JANX
Janux Therapeutics (JANX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wolfe Research | Upgraded | Peer Perform → Outperform | $23.00 | Aug 24, 2026 |
| Guggenheim | Maintained | Buy | $55.00 from $58.00 | Aug 7, 2026 |
| Truist Securities | Initiated Coverage | Buy | $26.00 from $80.00 | Jun 25, 2026 |
| Guggenheim | Maintained | Buy | $58.00 from $68.00 | May 8, 2026 |
| Wedbush | Maintained | Outperform | $36.00 from $45.00 | May 8, 2026 |
| Piper Sandler | Maintained | Overweight | $26.00 from $30.00 | May 8, 2026 |
| Jones Trading | Maintained | Buy | $28.00 from $50.00 | Apr 28, 2026 |
| Barclays | Downgraded | Overweight → Underweight | $14.00 from $29.00 | Apr 20, 2026 |
| UBS | Downgraded | Buy → Neutral | $15.00 from $57.00 | Apr 15, 2026 |
| Guggenheim | Maintained | Buy | $68.00 from $72.00 | Feb 27, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $100.00 from $150.00 | Feb 27, 2026 |
| Clear Street | Downgraded | Buy → Hold | $12.00 from $32.00 | Jan 20, 2026 |
| Piper Sandler | Maintained | Overweight | $30.00 from $42.00 | Jan 16, 2026 |
| Barclays | Maintained | Overweight | $29.00 from $48.00 | Dec 17, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $45.00 from $70.00 | Dec 2, 2025 |
| B of A Securities | Maintained | Buy | $49.00 from $58.00 | Dec 2, 2025 |
| Clear Street | Maintained | Buy | $32.00 from $80.00 | Dec 2, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | $150.00 from $200.00 | Dec 2, 2025 |
| Stifel | Maintained | Buy | $38.00 from $46.00 | Dec 2, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $70.00 | Nov 25, 2025 |
Frequently asked questions
What is the latest analyst rating on JANX?
On Aug 24, 2026, Wolfe Research upgraded Janux Therapeutics to Outperform with a price target of $23.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.